Role of Complement-dependent Cytotoxicity Crossmatch and HLA Typing in Solid Organ Transplant - PubMed
Review
Role of Complement-dependent Cytotoxicity Crossmatch and HLA Typing in Solid Organ Transplant
Arpit Tiwari et al. Rev Recent Clin Trials. 2024.
Abstract
Background: Solid organ transplantation is a life-saving medical operation that has progressed greatly because of developments in diagnostic tools and histocompatibility tests. Crossmatching for complement-dependent cytotoxicity (CDC) and human leukocyte antigen (HLA) typing are two important methods for checking graft compatibility and reducing the risk of graft rejection. HLA typing and CDC crossmatching are critical in kidney, heart, lung, liver, pancreas, intestine, and multi-organ transplantation.
Methods: A systematic literature search was conducted on the internet, using PubMed, Scopus, and Google Scholar databases, to identify peer-reviewed publications about solid organ transplants, HLA typing, and CDC crossmatching.
Conclusion: Recent advances in HLA typing have allowed for high-resolution evaluation, epitope matching, and personalized therapy methods. Genomic profiling, next-generation sequencing, and artificial intelligence have improved HLA typing precision, resulting in better patient outcomes. Artificial intelligence (AI) driven virtual crossmatching and predictive algorithms have eliminated the requirement for physical crossmatching in the context of CDC crossmatching, boosting organ allocation and transplant efficiency. This review elaborates on the importance of HLA typing and CDC crossmatching in solid organ transplantation.
Keywords: CDC crossmatching; HLA; Solid organ; artificial intelligence; bone marrow.; transplantation.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC, Ozawa M. Lee PC, et al. Clin Transpl. 2007:219-26. Clin Transpl. 2007. PMID: 18642453
-
Utility of the virtual crossmatch in solid organ transplantation.
Amico P, Hönger G, Steiger J, Schaub S. Amico P, et al. Curr Opin Organ Transplant. 2009 Dec;14(6):656-61. doi: 10.1097/MOT.0b013e328331c169. Curr Opin Organ Transplant. 2009. PMID: 19741534 Review.
-
The evolution and clinical impact of human leukocyte antigen technology.
Gebel HM, Bray RA. Gebel HM, et al. Curr Opin Nephrol Hypertens. 2010 Nov;19(6):598-602. doi: 10.1097/MNH.0b013e32833dfc3f. Curr Opin Nephrol Hypertens. 2010. PMID: 20720491 Review.
-
Tafulo S, Osório E, Mendes C, Liwski R. Tafulo S, et al. Hum Immunol. 2024 Jan;85(1):110734. doi: 10.1016/j.humimm.2023.110734. Epub 2023 Nov 29. Hum Immunol. 2024. PMID: 38030522
-
Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
Argani H. Argani H. Exp Clin Transplant. 2019 Jan;17(Suppl 1):38-42. doi: 10.6002/ect.MESOT2018.L41. Exp Clin Transplant. 2019. PMID: 30777521 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials